Governance
An independent company

OWNERSHIP

We are an independent company, majority owned by our employees.

Since 2007, Ceva’s management has been supported by carefully chosen, long-term financial partners who share our values and vision. In early 2020, the employees reinforced their controlling position and a group of new investors got onboard.

Among them, a familiar name: German firm Klocke Gruppe. Ceva acquired their IDT animal health business in 2019. Other newcomers included Téthys Invest from France, Mitsui & Co. from Japan and PSP Investments, one of Canada’s largest pension funds.

All our historic minority investors, known as “Ceva friends”, agreed to roll over a significant portion of their investment. The Singaporean Temasek, along with EMZ and Sagard of France, the Chinese private equity fund HOPU Investments, and the US-based Continental Grain Company, are long-term partners.

The trust and support of these partners is essential for Ceva to achieve its financial goals and ensure the long-term independent future of the company.‎

Members of the Executive Committee

DR MARC PRIKAZSKY

CHAIRMAN & CEO

VALÉRIE MAZEAUD

EXECUTIVE VICE-PRESIDENT, LEGAL AFFAIRS

PASCAL ANJOT

EXECUTIVE VICE-PRESIDENT, INNOVATION & DEVELOPMENT

ALAIN DE WOILLEMONT

EXECUTIVE VICE-PRESIDENT, CHIEF FINANCIAL OFFICER

JEAN-MARCEL CIET

EXECUTIVE VICE-PRESIDENT, DIGITAL & SMART SOLUTIONS ACCELERATOR

DR JÉRÔME-ANDRÉ GAUTHIER

EXECUTIVE VICE-PRESIDENT, STRATEGY & BUSINESS DEVELOPMENT

DAVID DERAIN

EXECUTIVE VICE-PRESIDENT, HUMAN RESSOURCES

DR GABRIEL RSHAID

EXECUTIVE VICE-PRESIDENT, GLOBAL OPERATIONS & FRANCHISES

DR VÉRONIQUE KODJO

EXECUTIVE VICE-PRESIDENT, MANUFACTURING & SUPPLY CHAIN

GÉRALDINE KUTAS

EXECUTIVE VICE-PRESIDENT, CORPORATE AFFAIRS & COMMUNICATION

Together we are a force, our passion for what we do is what makes the difference.

Policies & Charters

Ethical Animal Welfare Charter

Group Corporate Social Responsability

2021 Non-Financial Performance Statement (NFPS)

Collaboration in more than 46 countries.
You are leaving the country website to access another site in the group. Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.
Close